Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim Your Discount
Claim MarketBeat All Access Sale Promotion
NASDAQ:SLGL

Sol-Gel Technologies (SLGL) Stock Price, News & Analysis

Sol-Gel Technologies logo
$76.73 +8.42 (+12.33%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$76.30 -0.43 (-0.56%)
As of 05/22/2026 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Sol-Gel Technologies Stock (NASDAQ:SLGL)

Advanced

Key Stats

Today's Range
$67.21
$76.83
50-Day Range
$63.31
$85.31
52-Week Range
$6.80
$97.97
Volume
76,842 shs
Average Volume
21,368 shs
Market Capitalization
$215.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$110.00
Consensus Rating
Moderate Buy

Company Overview

Sol-Gel Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
72nd Percentile Overall Score

SLGL MarketRank™: 

Sol-Gel Technologies scored higher than 72% of companies evaluated by MarketBeat, and ranked 206th out of 866 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sol-Gel Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 strong buy rating, 1 buy rating, 2 hold ratings, and no sell ratings.

  • Upside Potential

    Sol-Gel Technologies has a consensus price target of $110.00, representing about 43.4% upside from its current price of $76.73.

  • Amount of Analyst Coverage

    Sol-Gel Technologies has only been the subject of 2 research reports in the past 90 days.

  • Read more about Sol-Gel Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for Sol-Gel Technologies are expected to decrease in the coming year, from ($11.41) to ($14.72) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sol-Gel Technologies is -34.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sol-Gel Technologies is -34.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Sol-Gel Technologies has a P/B Ratio of 9.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Sol-Gel Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    4.22% of the float of Sol-Gel Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Sol-Gel Technologies has a short interest ratio ("days to cover") of 1.26, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Sol-Gel Technologies has recently increased by 112.64%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Sol-Gel Technologies does not currently pay a dividend.

  • Dividend Growth

    Sol-Gel Technologies does not have a long track record of dividend growth.

  • News Sentiment

    Sol-Gel Technologies has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Sol-Gel Technologies this week, compared to 2 articles on an average week.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $231,497.00 in company stock, which represents 0.1074% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Sol-Gel Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $231,497.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    66.51% of the stock of Sol-Gel Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    26.18% of the stock of Sol-Gel Technologies is held by institutions.

  • Read more about Sol-Gel Technologies' insider trading history.
Receive SLGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sol-Gel Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SLGL Stock News Headlines

Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
See More Headlines

SLGL Stock Analysis - Frequently Asked Questions

Sol-Gel Technologies' stock was trading at $42.14 at the start of the year. Since then, SLGL shares have increased by 82.1% and is now trading at $76.73.

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) announced its quarterly earnings data on Thursday, March, 19th. The company reported ($1.07) EPS for the quarter, missing analysts' consensus estimates of $0.39 by $1.46. The business had revenue of $0.70 million for the quarter, compared to analyst estimates of $6.50 million. Sol-Gel Technologies had a negative trailing twelve-month return on equity of 24.29% and a negative net margin of 31.60%.

Sol-Gel Technologies's stock reverse split on Monday, May 5th 2025.The 1-10 reverse split was announced on Thursday, May 1st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 2nd 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Sol-Gel Technologies (SLGL) raised $75 million in an initial public offering (IPO) on Thursday, February 1st 2018. The company issued 6,250,000 shares at a price of $11.00-$13.00 per share. ​Jefferies and BMO Capital Markets​ served as the underwriters for the IPO and JMP Securities and Raymond James​ were co-managers.

Sol-Gel Technologies' top institutional shareholders include Affinity Asset Advisors LLC (1.25%).
View institutional ownership trends
.

Shares of SLGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sol-Gel Technologies investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Pfizer (PFE), Alibaba Group (BABA), ADMA Biologics (ADMA) and Fortress Biotech (FBIO).

Company Calendar

Last Earnings
3/19/2026
Today
5/23/2026
Next Earnings (Estimated)
8/06/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - GENERIC DRG
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SLGL
CIK
1684693
Employees
50
Year Founded
1997

Price Target and Rating

High Price Target
$110.00
Low Price Target
$110.00
Potential Upside/Downside
+43.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.13 million
Net Margins
-31.60%
Pretax Margin
-31.60%
Return on Equity
-24.29%
Return on Assets
-18.73%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.37
Quick Ratio
4.37

Sales & Book Value

Annual Sales
$19.39 million
Price / Sales
11.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.19 per share
Price / Book
9.37

Miscellaneous

Outstanding Shares
2,810,000
Free Float
941,000
Market Cap
$215.61 million
Optionable
No Data
Beta
1.16

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:SLGL) was last updated on 5/23/2026 by MarketBeat.com Staff.
From Our Partners